Liothyronine Sodium Tablets, USP are a thyroid hormone drug indicated:
- As replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis.
- As pituitary thyroid-stimulating hormone (TSH) suppressants, in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s) and multinodular goiter.
- As diagnostic agents in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy.
![Liothyronine Sodium Tablets, USP](/sites/default/files/2018-09/Liothyronine-all-strength.jpg)
-
Compare toCytomel®*
Inactive Ingredients
Calcium sulfate dihydrate, corn starch, gelatin, magnesium stearate and mannitol.
Note: The product is gluten free.
*Cytomel® is a registered trademark of Pfizer, Inc.
![Liothyronine Sodium Tablets, USP](/sites/default/files/2018-09/Liothyronine-all-strength.jpg)
Liothyronine Sodium Tablets, USP (5 mcg)
-
Package size90 ct
-
Strength5 mcg
-
NDC Code42794-0018-12
![Liothyronine Sodium Tablets, USP (5 mcg)](/sites/default/files/2018-09/Liothyronine-Sodium-5mcg.jpg)
Liothyronine Sodium Tablets, USP (25 mcg)
-
Package size90 ct
-
Strength25 mcg
-
NDC Code42794-0019-12
![Liothyronine Sodium Tablets, USP (25 mcg)](/sites/default/files/2018-09/Liothyronine-Sodium-25mcg.jpg)
Liothyronine Sodium Tablets, USP (50 mcg)
-
Package size90 ct
-
Strength50 mcg
-
NDC Code42794-0020-12
![Liothyronine Sodium Tablets, USP (50 mcg)](/sites/default/files/2018-09/Liothyronine-Sodium-50mcg.jpg)